Cerulean Pharma Inc. (CERU) Appoints Interim Chief Financial Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (Nasdaq: CERU) today announced the appointment of Gregg Beloff, J.D., M.B.A., as Interim Chief Financial Officer.

"Gregg brings extensive financial experience and leadership to Cerulean," said Christopher D. T. Guiffre, President & Chief Executive Officer of Cerulean. "He has been the CFO of public and private life sciences companies and has a background in healthcare investment banking, so we will benefit from Gregg's deep knowledge of the life sciences industry and from his experience in managing, growing and building finance organizations."